Stellenwert der kontrastmittelunterstützten Sonographie (CEUS) im Vergleich zur konventionellen B-Bild Sonographie und der Referenzprozedur (KM-CT) in der Abgrenzung eines zentralen Lungentumors von einer nachgeschalteten Atelektase: eine retrospektive Studie

Ziel: Die Computertomographie (CT) mit Kontrastmittel wird als Standardverfahren in der differentialdiagnostischen Abklärung von Atelektasen (AT) der Lunge eingesetzt. Ziel dieser Untersuchung war es, die diagnostische Treffsicherheit von B-Bild-Sonographie (US) und kontrastunterstützter Sonographi...

Ausführliche Beschreibung

Gespeichert in:
1. Verfasser: Brickmann, Christian
Beteiligte: Görg, C. (Prof. Dr. med.) (BetreuerIn (Doktorarbeit))
Format: Dissertation
Sprache:Deutsch
Veröffentlicht: Philipps-Universität Marburg 2015
Innere Medizin
Ausgabe:http://dx.doi.org/10.17192/z2015.0625
Schlagworte:
Online Zugang:PDF-Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

1. Boffetta, P. and F. Nyberg (2003). "Contribution of environmental factors to cancer risk." British Medical Bulletin 68: 71-94.


2. Riede, U., et al. (2009). Basiswissen Allgemeine und Spezielle Pathologie, Springer Verlag, Berlin -Heidelberg.


3. Schmidt, G. (2004). Kursbuch Ultraschall, Thieme Verlag, Stuttgart.


4. Burns, P. N. (1996). "Harmonic imaging with ultrasound contrast agents." Clinical Radiology 51: 50-55.


5. Brambilla, E., et al. (2001). "The new World Health Organization classification of lung tumours." European Respiratory Journal 18(6): 1059-1068.


6. Schwenzer, N., et al. (2000). Computertomographie, Magnetresonanztherapie und Angiographie. Algemeine Chirurgie, Thieme, Stuttgart. 1.


7. Correas, J. M., et al. (2001). "Ultrasound contrast agents: properties, principles of action, tolerance, and artifacts." European Radiology 11(8): 1316-1328.


8. Piscaglia, F., et al. (2006). "The safety of Sonovue (R) in abdominal applications: Retrospective analysis of 23188 investigations." Ultrasound in Medicine and Biology 32(9): 1369-1375.


9. Blomley, M., et al. (2007). "WFUMB safety symposium on ultrasound contrast agents: Clinical applications and safety concerns." Ultrasound in Medicine and Biology 33(2): 180- 186.


10. de Jong, N., et al. (2000). "Optical imaging of contrast agent microbubbles in an ultrasound field with a 100-MHz camera." Ultrasound in Medicine and Biology 26(3): 487- 492.


11. Muller, N., et al. (2001). Radiologic diagnosis of diseases of the chest, Saunders.


12. Görg, C., et al. (2006). "Transcutaneous contrast enhanced sonography of the chest for evaluation of pleural based pulmonary lesions: experience in 137 patients." Ultraschall in der Medizin (Stuttgart, Germany : 1980) 27(5): 437-444.


13. Shepherd, F. A., et al. (2007). "The International Association for the study of Lung Cancer - Lung Cancer staging project: Proposals regarding the clinical staging of small cell Lung Cancer in the forthcoming (seventh) edition of the tumor, node, metastasis classification for Lung Cancer." Journal of Thoracic Oncology 2(12): 1067-1077.


14. Forsberg, F., et al. (1999). "Tissue-specific US contrast agent for evaluation of hepatic and splenic parenchyma." Radiology 210(1): 125-132.


15. Görg, C. and T. Bert (2006). "Second-generation sonographic contrast agent for differential diagnosis of perisplenic lesions." American Journal of Roentgenology 186(3): 621-626.


16. Thun, M. J., et al. (2008). "Lung Cancer Occurrence in Never-Smokers: An Analysis of 13


17. Bittner, R. C. and R. Felix (1998). "Magnetic resonance (MR) imaging of the chest: state-of- the-art." European Respiratory Journal 11(6): 1392-1404.


18. Wen, Q., et al. (2008). "Enhancement pattern of peripheral lung carcinoma:comparison between contrast-enhanced ultrasonography and contrast-enhanced computed tomography." Zhonghua yi xue za zhi 88(39): 2779-2782.


19. Linde, H. N. G., et al. (2012). "Contrast-Enhancend Sonography (CEUS) in Pneumonia: Typical Patterns and Clinical Value -a Retrospective Study on n=50 Patients." Ultraschall in Der Medizin 33(2): 146-151.


20. Lippert, H. (2003). Lehrbuch Anatomie. Hannover, Elsevier GmbH, München.


21. Tamura, A., et al. (1998). "Lipoid pneumonia in lung cancer: Radiographic and pathological features." Japanese Journal of Clinical Oncology 28(8): 492-496.


22. Görg, C., et al. (2005). "Contrast-enhanced sonography for differential diagnosis of pleurisy and focal pleural lesions of unknown cause." Chest 128(6): 3894-3899.


23. Detterbeck, F. C., et al. (2013). "Executive Summary Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines." Chest 143(5): 7S-37S.


24. Gramiak, R. and P. M. Shah (1968). "Echocardiography of the aortic root." Invest Radiol 3(5): 356-366.


25. Morel, D. R., et al. (2000). "Human pharmacokinetics and safety evaluation of SonoVue (TM), a new contrast agent for ultrasound imaging." Investigative Radiology 35(1): 80-85.


26. Bauer, A., et al. (1999). "Wideband harmonic imaging: A novel contrast ultrasound imaging technique." European Radiology 9: S364-S367.


27. Mathis, G. (2010). Bildatlas der Lungen-und Pleurasonographie, Springer Verlag.


28. Spitz, M. (2006). Cancer of the lung. Cancer Epidemiology and Prevention, Oxford University Press. 3rd Edition.


29. Cohorts and 22 Cancer Registry Studies." Plos Medicine 5(9): 1357-1371.


30. Lissner, J., et al. (1992). Grundlagen der radiologischen Diagnostik. Radiologie, Enke, Stuttgart.


31. Claudon, M., et al. (2008). "Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) -Update 2008." Ultraschall in Der Medizin 29(1): 28- 44.


32. Herold, G. (2009). Herold -Innere Medizin. Köln, Gerd Herold.


33. Rivera, M. P. and A. C. Mehta (2007). "Initial diagnosis of lung cancer -ACCP evidence- based clinical practice guidelines (2nd edition)." Chest 132(3): 131S-148S.


34. Schwaiblmair, M., et al. (2010). "Lipoid pneumonia -an underestimated syndrome?" Deutsche Medizinische Wochenschrift 135(1-2): 27-31.


35. Loose, R. (2008). Orientierungshilfe für bildgebende Untersuchungen -Empfehlung der Strahlenschutzkommission. Bonn, Strahlenschutzkommission Bundesministerium für Umwelt, Naturschutz und Reaktorsicherheit.


36. Görg, C. (2008). Perkutane kontrastunterstützte Sonographie am Thorax, Verlag Robert Gessler.


37. Olschewski, H., et al. (1999). "Physiology and pathophysiology of pulmonary circulation." Internist 40(7): 696-709.


38. Burns, P. N., et al. (2000). "Pulse inversion imaging of liver blood flow -Improved method for characterizing focal masses with microbubble contrast." Investigative Radiology 35(1): 58-71.


39. Thomas, M., et al. (2000). "Recommendations on the diagnosis of bronchial carcinoma.


40. Rott, H. D. (1999). "Safety of ultrasonic contrast agents. European Committee for Medical Ultrasound Safety." Eur J Ultrasound 9(2): 195-197.


41. NIH, U. (2010) SEER Cancer Statistics Review 1975-2006SEER Cancer Statistics Review 1975- 2006.


42. Eltorky, M., et al. (1990). "SIGNIFICANT CHANGES IN THE DISTRIBUTION OF HISTOLOGIC TYPES OF LUNG-CANCER -A REVIEW OF 4928 CASES." Cancer 65(10): 2361-2367.


43. Putz, R. and R. Pabst (2000). Sobotta -Atlas der Anatomie des Menschen. München, Urban und Fischer Verlag.


44. Cao, B.-S., et al. (2011). "Sonographically Guided Transthoracic Biopsy of Peripheral Lung and Mediastinal Lesions Role of Contrast-Enhanced Sonography." Journal of Ultrasound in Medicine 30(11): 1479-1490.


45. Blomley, M., et al. (1998). "Stimulated acoustic emission imaging ("sono-scintigraphy") with the ultrasound contrast agent Levovist: A reproducible Doppler ultrasound effect with potential clinical utility." Academic Radiology 5: S236-S239.


46. Goldstraw, P., et al. (2007). "The IASLC lung cancer staging project: Proposals for the revision of he TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours." Journal of Thoracic Oncology 2(8): 706-714.


47. Grouven, U., et al. (2007). "The kappa coefficient." Deutsche medizinische Wochenschrift (1946) 132 Suppl 1: e65-68.


48. Becker, H., et al. (2004). Therapie des kleinzelligen Lungenkarzinom -Interdisziplinäre Leitlinie der Deutschen Krebsgesellschaft, AWMF online. Nr. 032/006.


49. Detterbeck, F. C., et al. (2013). "The Stage Classification of Lung Cancer Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence- Based Clinical Practice Guidelines." Chest 143(5): E191-E210.


50. Görg, C. and T. Bert (2004). "Transcutaneous colour Doppler Sonography of lung consolidations: Review and pictorial essay part 1: Pathophysiologic and colour Doppler sonographic basics of pulmonary vascularity." Ultraschall in Der Medizin 25(3): 221-226.


51. Krogel, C. and A. Reissig (1999). Transthorakale Sonographie, Thieme, Stuttgart (1999).


52. Dietrich, C. F., et al. (2003). "Ultrasonography of pleura and lung." Ultraschall in Der Medizin 24(5): 303-311.


53. Krestan, C. (2005). "Ultrasound contrast agents: substance classes, pharmacokinetics, clinical indications, safety profile." Radiologe 45(6): 513-519.


54. Ulmer, W., et al. (1991). Die Lungenfunktion, Physiologie und Pathophysiologie, Methodik, Georg Thieme Verlag -Stuttgart -New York.


55. Jemal, A., et al. (2011). "Global cancer statistics." CA: a cancer journal for clinicians 61(2): 69-90.


56. Duncker, H. and W. Kummer (2008). Anatomie, Elsevier Verlag München.


57. Schlungbaum, W., et al. (1994). Medizinische Strahlenkunde. Medizinische Strahlenkunde, DeGruyter, Berlin -New York.


58. Hsu, W. H., et al. (1996). "Color Doppler ultrasound signals of thoracic lesions -Correlation with resected histologic specimens." American Journal of Respiratory and Critical Care Medicine 153(6): 1938-1951.


59. Görg, C., et al. (2005). "Colour Doppler ultrasound mapping of chest wall lesions." British Journal of Radiology 78(928): 303-307.


60. Lam, W. K., et al. (2004). "Lung cancer epidemiology and risk factors in Asia and Africa." International Journal of Tuberculosis and Lung Disease 8(9): 1045-1057.


61. Görg, C., et al. (2003). "Color Doppler sonographic mapping of pulmonary lesions - Evidence of dual arterial supply by spectral analysis." Journal of Ultrasound in Medicine 22(10): 1033-1039.


62. Görg, C., et al. (2006). "Contrast-enhanced sonography of the lung for differential diagnosis of atelectasis." Journal of Ultrasound in Medicine 25(1): 35-39.


63. Nakanishi, M., et al. (2008). "Multi-arterial infusion chemotherapy for non-small cell lung carcinoma -Significance of detecting feeding arteries and tumor staining." Lung Cancer 61(2): 227-234.


64. Bachmann, C. and C. Gorg (2005). "Color Doppler sonographic findings in focal spleen lesions." European Journal of Radiology 56(3): 386-390.


65. Wardlaw, J. M., et al. (2002). "Interobserver variability of magnetic resonance angiography in the diagnosis of carotid stenosis -effect of observer experience." Neuroradiology 44(2): 126-132.


66. Mornstein, V. (1997). "Cavitation-induced risks associated with contrast agents used in ultrasonography." European Journal of Ultrasound 5(2): 101-111.


67. Sant, M., et al. (2009). "EUROCARE-4. Survival of cancer patients diagnosed in 1995-1999. Results and commentary." European Journal of Cancer 45(6): 931-991.


68. Ye, X.-D., et al. (2013). "Assessment of the feeding arteries by three-dimensional computed tomography angiography prior to multi-arterial infusion chemotherapy for lung cancer." Oncology Letters 5(1): 363-367.


69. Detterbeck, F. C., et al. (2009). "The New Lung Cancer Staging System." Chest 136(1): 260- 271.


70. Jakobsen, J. A., et al. (2005). "Safety of ultrasound contrast agents." European Radiology 15(5): 941-945.